Clinical trials for Amyloidosis

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Amyloidosis. For all clinical trials, go to clinical trials search

This list shows clinical trials for Amyloidosis

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Amyloidosis
Title Recruitment status Location
A Safety and Tolerability Study of an Investigational Drug, ALN-TTRSC02, in Healthy Subjects Recruiting United Kingdom
Open-Label Extension Assessing Long Term Safety and Efficacy of IONIS-TTR Rx in Familial Amyloid Polyneuropathy (FAP) Recruiting United Kingdom
The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis Recruiting United Kingdom
CATALYST: Carfilzomib-Thal-Dex in relapsed AL Amyloidosis Recruiting United Kingdom
Study to assess the efficacy and safety of treatment with Kiacta in adult patients with AA amyloidosis. Amyloidosis is the generic term for a number of diseases related to the aggregation of fibrillar proteins (amyloid) in specific body organs Recruiting United Kingdom
The VITAL Amyloidosis Study, a Global Phase 3, Efficacy and Safety Study of NEOD001 in Patients With AL Amyloidosis Recruiting United Kingdom
Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis Recruiting United Kingdom
The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant Not recruiting United Kingdom
Velcade™ (bortezomib) combination chemotherapy in AL amyloidosis Not Recruiting United Kingdom
An open-label, phase II dose titration study of ACZ885 (human anti-IL-1beta monoclonal antibody) to assess the clinical efficacy, safety, pharmacokinetics and pharmacodynamics in patients with NALP3 mutations - A2102 Not Recruiting United Kingdom

Page last reviewed:

Next review due: